TITLE

IS HCMV VACCINE AN UNMET NEED? THE STATE OF ART OF VACCINE DEVELOPMENT

AUTHOR(S)
CHIURCHIÙ, S.; CALÒ CARDUCCI, F. I.; ROCCHI, F.; SIMONETTI, A.; BONATTI, G.; SALMASO, S.; MELCHIORRI, D.; PANI, L.; ROSSI^1, P.
PUB. DATE
January 2013
SOURCE
International Journal of Immunopathology & Pharmacology;Jan-Mar2013, Vol. 26 Issue 1, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
91993400

 

Related Articles

  • Prospects of a vaccine for the prevention of congenital cytomegalovirus disease. Plachter, Bodo // Medical Microbiology & Immunology;Dec2016, Vol. 205 Issue 6, p537 

    Congenital human cytomegalovirus (HCMV) infection is one leading cause of childhood disabilities. Prevention of congenital HCMV disease by vaccination has consequently been identified as a priority public healthcare goal. Several vaccine candidates have been introduced in the past that aimed at...

  • Congenital Cytomegalovirus Infection and Its Prevention. Plotkin, Stanley A. // Clinical Infectious Diseases;4/1/2004, Vol. 38 Issue 7, p1038 

    Reports on the congenital cytomegalovirus infection and the methods of prevention. Analysis of Institute of Medicine of the National Academy of Sciences; Priority for development of a vaccine against human cytomegalovirus (HCMV); Higher risk to the fetus of women who are tested seropositive or...

  • Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. Tomić, Adriana; Varanasi, Pavankumar R.; Golemac, Mijo; Malić, Suzana; Riese, Peggy; Borst, Eva M.; Mischak-Weissinger, Eva; Guzmán, Carlos A.; Krmpotić, Astrid; Jonjić, Stipan; Messerle, Martin // PLoS Pathogens;12/1/2016, Vol. 12 Issue 12, p1 

    Development of an effective vaccine against human cytomegalovirus (HCMV) is a need of utmost medical importance. Generally, it is believed that a live attenuated vaccine would best provide protective immunity against this tenacious pathogen. Here, we propose a strategy for an HCMV vaccine that...

  • Influenza Vaccines: Unmet Needs and Recent Developments. Ji Yun Noh; Woo Joo Kim // Infection & Chemotherapy;Dec2013, Vol. 45 Issue 4, p375 

    Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they...

  • Wellcome Trust, Merck Team Up to Create £90M Vaccine Program. Moran, Nuala // BioWorld International;9/23/2009, Vol. 14 Issue 38, p1 

    The article reports on a partnership between Wellcome Trust medical charity and Merck & Co. to set up a nonprofit joint venture to develop vaccines against diseases that are prevalent in developing countries. The two will make a combined contribution of 90 million British pounds to Hilleman...

  • Vaccines: Market on the Rebound. Pasternak, Andrew; Sabow, Adam; Chadwick-Jones, Andrew // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p110 

    The article looks at the opportunities provided by the growth of the vaccine market to pharmaceutical companies. Several factors that contributed to the recovery of the market include the introduction of new vaccines that target unmet medical needs and consolidation of manufacturers. The article...

  • Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Sirskyj, Danylo; Diaz-Mitoma, Francisco; Golshani, Ashkan; Kumar, Ashok; Azizi, Ali // Immunology & Cell Biology;Jan2011, Vol. 89 Issue 1, p81 

    The application of the fields of pharmacogenomics and pharmacogenetics to vaccine design has been recently labeled 'vaccinomics'. This newly named area of vaccine research, heavily intertwined with bioinformatics, seems to be leading the charge in developing novel vaccines for currently unmet...

  • Manufacturing VACCINES for the Developing World. Mukherjee, Bhawani; Gerson, Donald F. // BioPharm International;Oct2004, Vol. 17 Issue 10, p24 

    Explains the requirements for manufacturing vaccines for developing countries. Vaccines under development for diseases that major threats to world public health; Estimates of the vaccination needs of the developing world; Requirements for vaccine manufacturing facilities; Vaccine factory design...

  • Malaria may have met its match � in a goat!. Williams, Stephen // African Business;Feb2002, Issue 273, p37 

    Reports on the effort of scientist to develop a malaria vaccine in the United States. Price of the vaccine; Effectiveness of the vaccine; Information on transgenic animals.

  • Improved anthrax vaccine is needed, claims report. Marwick, Charles // BMJ: British Medical Journal (International Edition);3/16/2002, Vol. 324 Issue 7338, p630 

    Reports on the need for a new and improved vaccine to fight anthrax. Disadvantages of the current anthrax vaccine; Details of a report on the vaccine by Dr. Brian Strom; Prospects for developing a new vaccine; Mentions the distribution of anthrax spores in the United States through the postal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics